Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC
NCT04922073 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2021-08-27
Summary
The aim of the study is to assess the practical usability of EGFR mutation detection in ctDNA from early NSCLC.
Conditions
- Lung Neoplasms
Sponsors & Collaborators
-
GENECAST Co., Ltd.
collaborator UNKNOWN -
Samsung Medical Center
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-01
- Primary Completion
- 2022-01-31
- Completion
- 2022-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
Analysis of Plasma Tumor DNA in Lung Cancer Patients
NCT01930474 ·Status: UNKNOWN
-
A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer
NCT04254497 ·Status: COMPLETED
-
Detection Cell Free DNA in Lung Cancer Patients
NCT02738593 ·Status: UNKNOWN
-
Liquid Biopsy Using Methylation Sequencing for Lung Cancer
NCT04253509 ·Status: COMPLETED
-
Detection of EGFR Mutation in Malignant Pleural Effusion of Lung Cancer Patients and Cancer Cell Lines Establishment
NCT00752076 ·Status: UNKNOWN ·Phase: NA
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Korean Registry of Non-Small Cell Lung Cancer Patients with EGFR Mutation
NCT06247280 ·Status: ACTIVE_NOT_RECRUITING
-
Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers
NCT01585545 ·Status: ENROLLING_BY_INVITATION
-
Correlation Between EGFR Mutation Using cfDNAs and Circulating Tumor Cells in Patients With NSCLC
NCT02422628 ·Status: UNKNOWN
-
Precision Diagnosis for Intraoperative Frozen Section of Early Stage Lung Cancer
NCT02941003 ·Status: UNKNOWN ·Phase: NA
-
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
NCT07287904 ·Status: NOT_YET_RECRUITING
-
Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy
NCT01482585 ·Status: UNKNOWN
-
CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis From Colorectal Cancer: candiDate Selection for Local AblaTive thErapy
NCT04704960 ·Status: UNKNOWN
-
Comparison of Genomic and Transcriptomic Patterns Between CTC and Metastatic Tumormetastatic Tumor
NCT04932343 ·Status: UNKNOWN
-
Liquid Biopsy in Lung Cancer
NCT03479099 ·Status: COMPLETED
-
Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
NCT01450553 ·Status: UNKNOWN
-
Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces
NCT07066813 ·Status: RECRUITING
-
ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS
NCT03172156 ·Status: COMPLETED
-
Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC
NCT05641870 ·Status: UNKNOWN
-
Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNA
NCT02833467 ·Status: UNKNOWN
-
Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA
NCT01309087 ·Status: COMPLETED
-
Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer
NCT04814407 ·Status: RECRUITING
-
Pronostic and Predictive Value of EMT in Localized Lung Cancer
NCT03509779 ·Status: RECRUITING
-
AI-Driven Precision Diagnostic System for Lung Cancer Based on Liquid Biopsy
NCT07009769 ·Status: COMPLETED
-
Analysis of Driver Gene Mutation in Early Stage Non-small Cell Lung Cancer
NCT04266691 ·Status: COMPLETED